2008
DOI: 10.1186/cc6211
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of outcome in myxoedema coma: a study from a tertiary care centre

Abstract: Background With the easy availability of thyroid hormone assays, thyroid disorders are now recognised even in a subclinical state. However, patients are still seen with advanced manifestations of the disease, particularly in developing countries. This observational study analysed the predictors of outcome in patients with myxoedema coma and tested the validity of different modules to define morbidity and mortality in these patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
68
0
5

Year Published

2012
2012
2018
2018

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 120 publications
(78 citation statements)
references
References 20 publications
5
68
0
5
Order By: Relevance
“…Triiodothyronine can be added to therapy at 10-20 mg bolus followed by 10 μg every 4-6 hours. This initial plan can be followed by L-T4 maintenance therapy once the patient is stable (216,217) (B,B).…”
Section: How To Treat Myxedema Coma?mentioning
confidence: 99%
“…Triiodothyronine can be added to therapy at 10-20 mg bolus followed by 10 μg every 4-6 hours. This initial plan can be followed by L-T4 maintenance therapy once the patient is stable (216,217) (B,B).…”
Section: How To Treat Myxedema Coma?mentioning
confidence: 99%
“…A precipitating factor was evident in only 34 of 77 cases in an analysis of myxedema coma reported by Forester (7). Sepsis was the most common precipitating factor among the 23 patients with myxedema coma in a study reported by Dutta et al (9).…”
Section: Discussionmentioning
confidence: 89%
“…Although elevated TSH levels are common in patients with myxedema coma, it is not a sine qua non. For example, patients with pituitary disease would not have elevated TSH levels but may have myxedema coma as has been reported (9). Thus, we have included TSH levels in our screening tool.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The mortality rates may be as high as 25-60% even with best possible treatment [56][57][58][59][60] . It presents as central nervous system dysfunction, defective thermoregulation, and cardiopulmonary decompensation.…”
Section: Myxedema Comamentioning
confidence: 99%